Edit |   |
---|---|
Product Name | Boceprvir |
Description | Boceprvir is a small molecule which can act as a HCV NS3 protease inhibitor. It is provided as a powder. This product acts on the following target types: Protease, Cytochrome. This product acts on the following biochemical pathways: Cytokine. This product may be of interest in the following research areas and diseases: Immunology, Infectious disease. This product may act as a Coronavirus inhibitor: Inhibits key SARS-CoV-2 protease, Mpro (3CLpro) in vitro, and SARS-CoV-2 in cells. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 519.7 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Boceprevir, (1R,2S,5S)-N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-3-azabicyclo[3.1.0]hexane-2-carboxamide, SCH 503034, 394730-60-0 |
Gene, Accession, CAS # | CAS: 394730-60-0 |
Catalog # | abx283135 |
Price | please inquire |
Order / More Info | Boceprvir from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950